Rainbow Childrens Medicare (Mid Cap) Share Target 2025, 2026 To 2035
|
Rainbow Children's Medicare Limited |
|||
|
Price: ₹1,443.15 (-1.03%) | ||
| 52 Week Low: ₹1,079.10 52 Week High: ₹1,709.60 |
|||
| Market Capital: 12,637.5 Crore (Midcap) | |||
| Healthcare -> Medical Care Facilities | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Rainbow Childrens Medicare Share Price Target For 2025
- 1.1.1: Rainbow Childrens Medicare Share Price Target Table For 2025
- 1.1.2: Short-Term Technical Outlook
- 1.2: Rainbow Childrens Medicare Share Price Target For 2026
- 1.2.1: Rainbow Childrens Medicare Share Price Target Table For 2026
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Rainbow Childrens Medicare Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
- 3: Rainbow Childrens Medicare Brief Company Overview
- 4: Rainbow Childrens Medicare Financial Performance
- 4.0.1: Is Rainbow Childrens Medicare A Good Buy For Long Term?
Rainbow Childrens Medicare, a Mid Cap company in the Medical Care Facilities Industry has delivered 18.8% returns in 1-year showing 9.6% quarterly revenue growth with 17.2% profit margin.
To predict the Rainbow Childrens Medicare's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Rainbow Childrens Medicare Share Price Target For 2025
The line chart displays the monthly closing prices of Rainbow Childrens Medicare with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Rainbow Childrens Medicare shares in 2025, see the table below.
Rainbow Childrens Medicare Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 1577.25 (+9.28%) | Price Action: 18 Nov 2024 Low |
| 2025 Target 2 | 1560.0 (+8.09%) | Price Action: 23 Dec 2024 High |
| 2025 Target 1 | 1540.0 (+6.71%) | Price Action: 05 Nov 2024 Low |
| Current Price | 1443.15 | Rainbow Childrens Medicare's share price as of 21 Jan 2025 |
| Stop Loss 1 | 1399.88 (-3%) | Price Action: Mar 2024 High |
| Stop Loss 2 | 1385.05 (-4.03%) | Price Action: 03 Oct 2024 Low |
| Stop Loss 3 | 1370.0 (-5.07%) | Price Action: 17 May 2024 High |
Short-Term Technical Outlook
Current Technical Position: Rainbow Childrens Medicare is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 25-day moving average at ₹1532.64 serves as the nearest technical reference point.
Historical Returns: 3-month: -10.6% | 6-month: +22.15% | 1-year: +18.84%
Rainbow Childrens Medicare Share Price Target For 2026
The line chart displays the monthly closing prices of Rainbow Childrens Medicare with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Rainbow Childrens Medicare shares in 2026, see the table below.
Rainbow Childrens Medicare Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 2164.28 (+49.96%) | Price Action: Chart |
| 2026 Target 2 | 2123.93 (+47.17%) | Price Action: Chart |
| 2026 Target 1 | 2102.9 (+45.71%) | Fibonacci Extension Level 64.90% |
| Current Price | 1443.15 | Rainbow Childrens Medicare's share price as of 21 Jan 2025 |
| Stop Loss 1 | 1292.45 (-10.45%) | Price Action: 23 Feb 2024 High |
| Stop Loss 2 | 1279.0 (-11.38%) | Price Action: 29 May 2024 High |
| Stop Loss 3 | 1266.0 (-12.28%) | Price Action: 01 Jul 2024 High |
Long-Term Technical Outlook
52-Week Range Analysis: Rainbow Childrens Medicare is currently trading at 57.7% of its 52-week range (₹1079.1 - ₹1709.6).
Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.
Long-Term Performance: 1-year: +18.84% | 3-year: NA | 5-year: NA
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Rainbow Childrens Medicare Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹1,443.15 | ||
| 2025 | ₹2,627.67 | +82.07% | ₹2,667.09 |
| 2026 | ₹3,916.79 | +49.05% | ₹3,975.54 |
| 2027 | ₹5,061.43 | +29.22% | ₹5,137.35 |
| 2028 | ₹7,120.65 | +40.68% | ₹7,227.46 |
| 2029 | ₹10,905.11 | +53.14% | ₹11,068.69 |
| 2030 | ₹13,468.17 | +23.5% | ₹13,670.19 |
| 2031 | ₹18,267.68 | +35.63% | ₹18,541.70 |
| 2032 | ₹26,466.33 | +44.88% | ₹26,863.32 |
| 2033 | ₹35,339.26 | +33.52% | ₹35,869.35 |
| 2034 | ₹46,059.62 | +30.33% | ₹46,750.51 |
| 2035 | ₹59,675.60 | +29.56% | ₹60,570.73 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Rainbow Childrens Medicare Brief Company Overview
Rainbow Children's Medicare Limited: A Healthcare Trailblazer Established in 1998, Rainbow Children's Medicare Limited has emerged as a renowned multi-specialty healthcare provider in India, specializing in paediatric and obstetrics, and gynaecology services. Key Services:...
Rainbow offers a comprehensive range of paediatric and gynaecological treatments, including advanced care for children and expecting mothers. Diverse Product Range: From IVF to bone marrow transplant, Rainbow's diverse product portfolio caters to a wide spectrum of healthcare needs. Commitment to Quality: Driven by a patient-centric approach, Rainbow is dedicated to delivering high-quality healthcare services and ensuring the well-being of its patients. Headquartered in Hyderabad, Rainbow has established a strong market presence across India. Its reputation for excellence in the healthcare industry has solidified its position as a trusted provider of specialized medical care.Rainbow Childrens Medicare Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 12,637.5 Crore | Market valuation of Rainbow Childrens Medicare's shares. |
| Revenue (TTM) | 1,272.76 Crore | Total revenue generated by Rainbow Childrens Medicare over the past twelve months. |
| Net Income (TTM) | +219.62 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +26.91% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +17.25% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+9.6% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
+7.3% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
55.14 | Company's total debt divided by total shareholder equity. |
| Total Debt | 631.29 Crore | Sum of Rainbow Childrens Medicare's current & long-term financial obligations. |
| Total Cash | 464.61 Crore | Total amount of liquid funds available to Rainbow Childrens Medicare. |
| Beta | 0.34 | Beta is less than 1 indicating that the Rainbow Childrens Medicare's price is less volatile than the market. |
Is Rainbow Childrens Medicare A Good Buy For Long Term?
Rainbow Childrens Medicare's recent financial performance indicates it as an average buy for long-term investment. With a 57.33% return over the past 12 months and a 17.25% profit margin, the company has shown steady growth. However, its revenue growth of 9.6% in the last quarter and debt of 631.29 Crore should be considered before making a decision.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
